Vaccine Platform Expansion

Matthew discusses how Moderna accelerated their vaccine platform due to Covid, leading to opportunities for investing in additional vaccines. He emphasizes the importance of derisking a vertical before heavily investing in it. Jesse raises concerns about potential risks Moderna may face in the future.